A Far-red Fluorescent Contrast Agent to Image Epidermal Growth Factor Receptor Expression

Photochemistry and Photobiology

Volumn 79, Issue 3, 2004, Pages 272-279

  Hsu, Elizabeth R ^a   Anslyn, Eric V ^b   Dharmawardhane, Su ^b   Alizadeh Naderi, Reza ^c   Aaron, Jesse S ^a   Sokolov, Konstantin V ^c   El Naggar, Adel K ^c   Gillenwater, Ann M ^c   Richards Kortum, Rebecca R ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXA FLUOR 660 STREPTAVIDIN; BOVINE SERUM ALBUMIN; CONTRAST MEDIUM; DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE; POVIDONE; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY CANCER; FAR RED LIGHT; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; MOUTH CARCINOMA; OPTICS; PERMEABILITY; PRECANCER; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

BIOPSY; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; FLUOROMETRY; HUMANS; MICROSCOPY, CONFOCAL; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAINING AND LABELING; STREPTAVIDIN;

ALEXA; BOVINAE;

EID: 1942531348     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/FR-03-15.1     Document Type: Article

References (52)

1. Andersson-Engels, S., C. a. Klinteberg, K. Svanber and S. Svanber (1997) In vivo fluorescence imaging for tissue diagnostics. Phys. Med. Biol. 42, 815-824.
2. Ferris, D. G., R. A. Lawhead, E. D. Dickman, N. Holtzapple, J. A. Miller, S. Grogan, S. Bambot, A. Agrawal and M. L. Faupel (2001) Multimodal hyperspectral imaging for the noninvasive diagnosis of cervical neoplasia. J. Low. Genital Tract Dis. 5(2), 65-72.
3. Gurjar, R. S., V. Backman, L. T. Perelman, I. Georgakoudi, K. Badizadegan, I. Itzkan, R. R. Dasari and M. S. Feld (2001) Imaging human epithelial properties with polarized light-scattering spectroscopy. Nat. Med. 7(11), 1245-1248.
4. Collier, T., A. Lacy, R. Richards-Kortum, A. Malpica and M. Follen (2002) Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue. Acad. Radiol. 9, 504-512.
5. White, W. M., M. Rajadhyaksha, S. Gonzalez, R. L. Fabian and R. R. Anderson (1999) Noninvasive imaging of human oral mucosa in vivo by confocal reflectance microscopy. Laryngoscope 109, 1709-1717.
6. Sokolov, K., R. Drezek, K. Gossage and R. Richards-Kortum (1999) Reflectance spectroscopy with polarized light: is it sensitive to cellular and nuclear morphology? Opt. Express 5(13), 302.
7. Sokolov, K., M. Follen and R. Richards-Kortum (2002) Optical spectroscopy for detection of neoplasia. Curr. Opin. Chem. Biol. 6, 651-658.
8. Utzinger, U., M. Brewer, E. Silva, D. Gersheson, R. C. Blast, Jr., M. Follen and R. Richards-Kortum (2001) Reflectance spectroscopy for in vivo characterization of ovarian tissue. Lasers Surg. Med. 28, 56-66.
9. Gillenwater, A., R. Jacob and R. Richards-Kortum (1998) Fluorescence spectroscopy: a technique with potential to improve the early detection of aerodigestive tract neoplasia. Head Neck 20, 556-562.
10. Ramanujam, N. (2000) Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia 2(1-2), 89-117.
11. Wagnières, G. A., W. M. Star and B. C. Wilson (1998) In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem. Photobiol. 68(5), 603-632.
12. Müller, M. G., T. A. Valdez, I. Georgakoudi, V. Backman, C. Fuentes, S. Kabani, N. Laver, Z. Wang, C. W. Boone, R. R. Dasari, S. M. Shapshay and M. S. Feld (2003) Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer 97(7), 1681-1692.
13. Svistun, E., R. Alizadeh-Naderi, A. El-Naggar, R. Jacob, A. Gillenwater and R. Richards-Kortum (2003) Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence. Head Neck 205-215.
14. Schantz, S. P., V. Kolli, H. E. Savage, G. Yu, J. P. Shah, D. E. Harris, A. Katz, R. R. Alfano and A. G. Huvos (1998) In vivo native cellular fluorescence and histological characteristics of head and neck cancers. Clin. Cancer Res. 4, 1177-1182.
15. Betz, C. S., M. Mehlmann, K. Rick, H. Stepp, G. Grevers, R. Baumgartner and A. Leunig (1999) Autofluorescence imaging and spectroscopy of normal and malignant mucosa in patients with head and neck cancer. Lasers Surg. Med. 25, 323-334.
16. Heintzelman, D. L., U. Utzinger, H. Fuchs, A. Zuluaga, K. Gossage, A. M. Gillenwater, R. Jacob, B. Kemp and R. R. Richards-Kortum (2000) Optimal excitation wavelengths for in vivo detection of oral neoplasia using fluorescence spectroscopy. Photochem. Photobiol. 72(1), 103-113.
17. Srinivas, P. R., B. S. Kramer and S. Srivastava (2001) Trends in biomarker research for cancer detection. Lancet Oncol. 2, 698-704.
18. Kannan, S., P. Balaram, G. J. Chandran, M. R. Pillai, B. Mathew and M. K. Nair (1994) Co-expression of ras p21 and epidermal growth factor receptor during various stages of tumour progression in oral mucosa. Tumor Biol. 15, 73-81.
19. Shintani, S., T. Matsumura, R. E. Alcalde and Y. Yoshihama (1996) Sequential expression of myc-, ras-, oncogene products and EGF receptor during DMBA-induced tongue carcinogenesis. Int. J. Oncol. 8, 821-826.
20. Shin, D. M., J. Y. Ro, W. K. Hong and W. N. Hittelman (1994) Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54, 3153-3159.
21. van Oijen, M. G. C. T., G. Rijksen, F. W. ten Broek and P. J. Slootweg (1998) Increased expression of epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas independent of tobacco and alcohol abuse. Oral Dis. 4, 4-8.
22. Nouri, A. M. E., C. Thompson, H. Cannell, M. Symes, S. Purkiss and Z. Amirghofran (2000) Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines. Int. J. Mol. Med. 6, 495-500.
23. Todd, R. and D. T. W. Wong (1999) Epidermal growth factor receptor (EGFR) biology and human oral cancer. Histol. Histopathol. 14, 491-500.
24. Soukos, N. S., M. R. Hamblin, S. Keel, R. L. Fabian, T. F. Deutsch and T. Hasan (2001) Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res. 61, 4490-4496.
25. Sokolov, K., J. Galvan, A. Myakov, A. Lacy, R. Lotan and R. Ricards-Kortum (2002) Realistic three-dimensional epithelial tissue phantoms for biomedical optics. J. Biomed. Opt. 71(1), 148-156.
26. Anido, J., P. Matar, J. Albanell, M. Guzmán, F. Rojo, J. Arribas, S. Averbuch and J. Baselga (2003) ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpression breast cancer cells. Clin. Cancer Res. 9, 1274-1283.
27. King, I. and A. C. Sartorelli (1989) Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells. Cancer Res. 49(20), 5677-5681.
28. Reiss, M., E. B. Stash, V. F. Vellucci and Z.-L. Zhou (1991) Activation of the autocrine transforming growth factor α pathway in human squamous carcinoma cells. Cancer Res. 51(23 Pt 1), 6254-6262.
29. Baselga, J. (2001) The EGFR as a target for anticancer therapy - focus on cetuximab. Eur. J. Cancer 37, S16-S22.
30. Becker, A., C. Hessenius, K. Licha, B. Ebert, U. Sukowski, W. Semmier, B. Wiedenmann and C. Grötzinger (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat. Biotechnol. 19, 327-331.
31. Bugaj, J. E., S. Achilefu, R. B. Dorshow and R. Rajagopalan (2001) Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. J. Biomed. Opt. 6(2), 122-133.
32. Sevick-Muraca, E. M., J. P. Houston and M. Gurfinkel (2002) Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6, 642-650.
33. Ballou, B., G. W. Fisher, T. R. Hakala and D. L. Farkas (1997) Tumor detection and visualization using cyanine fluorochrome-labeled antibodies. Biotechnol. Prog. 13, 649-658.
34. Krishna, G., K.-J. Chen, C.-C. Lin and A. A. Nomeir (2001) Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, caco-2. Int. J. Pharm. 222, 77-89.
35. Viegas, T. X., A. H. Hikal and R. W. Cleary (1998) Formulation of penetration enhancers in polymers. Drug Dev. Ind. Pharm. 14(6), 855-866.
36. Yu, Z.-W. and P. J. Quinn (1995) Dimethyl sulphoxide: a review of its applications in cell biology. Biosci. Rep. 14(6), 259-281.
37. Yu, Z.-W. and P. J. Quinn (1998) The modulation of membrane structure and stability by dimethyl sulphoxide. Mol. Membr. Biol. 15, 59-68.
38. Sokolov, K., M. Follen, J. Aaron, I. Pavlova, A. Malpica, R. Lotan and R. Richards-Kortum (2003) Real time vital optical imaging of pre-cancer using anti-EGF receptor antibodies conjugated to gold nano-particles. Cancer Res. 63(9), 1999-2004.
39. Sung, K. B., C. Liang, M. Descour, T. Collier, M. Follen, A. Malpica and R. Richards-Kortum (2002) Near real time in vivo fibre optic confocal microscopy: sub-cellular structure resolved. J. Microsc. 207(Pt 2), 137-145.
40. Sung, K. B., C. Liang, M. Descour, M. Follen and R. Richards-Kortum (2002) Fiber optic confocal microscope with miniature objective for in-vivo imaging. IEEE Trans. Biomed. Eng. 49(10), 1168-1172.
41. Anikijenko, P., L. T. Vo, E. R. Murr, J. Carrasco, W. J. McLaren, Q. Chen, S. G. Thomas, P. M. Delaney and R. G. King (2001) In vivo detection of small subsurface melanomas in athymic mice using noninvasive fiber optic confocal imaging. J. Investig. Dermatol. 117, 1442-1448.
42. Gmitro, A. F. and D. Aziz (1993) Confocal microscopy through a fiber-optic imaging bundle. Opt. Lett. 18(8), 565-567.
43. Juškaitis, R. and T. Wilson (1992) Imaging in reciprocal fibre-optic based confocal scanning microscopes. Opt. Commun. 92, 315-325.
44. Swindle, L. D., S. G. Thomas, M. Freeman and P. M. Delaney (2003) View of normal human skin in vivo as observed using fluorescent fiber-optic confocal microscopic imaging. J. Investig. Dermatol. 121, 706-712.
45. Boerman, O. C., F. G. van Schaijk, W. J. G. Oyen and F. H. M. Corstens (2003) Pretargeted radioimmunotherapy of cancer: progress step by step. J. Nucl. Med. 44(3), 400-411.
46. Moro, M., M. Pelagi, G. Fulci, G. Paganelli, P. Dellabona, G. Casorati, A. G. Siccardi and A. Corti (1997) Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor α. Cancer Res. 57, 1922-1928.
47. Reali, E., J. W. Greiner, A. Corti, H. J. Gould, F. Bottazzoli, G. Paganelli, J. Schlom and A. G. Siccardi (2001) IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. Cancer Res. 61, 5517-5522.
48. Schechter, B., R. Arnon, M. Wilchek, J. Schlessinger, E. Hurwitz, E. Aboud-Pirak and M. Sela (1991) Indirect immunotargeting of Cis-Pt to human epidermoid carcinoma KB using the avidin-biotin system. Int. J. Cancer 48, 167-172.
49. Guttinger, M., F. Guidi, M. Chinol, E. Reali, F. Veglia, G. Viale, G. Paganelli, A. Corti and A. G. Siccardi (2000) Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte tumor bridging. Cancer Res. 60, 4211-4215.
50. Wilbur, D. S., P. M. Pathare, D. K. Hamlin, P. S. Stayton, R. To, L. A. Klumb, K. R. Buhler and R. L. Vessella (1999) Development of new biotin/streptavidin reagents for pretargeting. Biomol. Eng. 16, 113-118.
51. Wood, G. S. and R. Warnke (1981) Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J. Histochem. Cytochem. 29(10), 1196-1204.
52. Moldwin, R. M. and G. R. Sant (2002) Interstitial cystitis: a pathophysiology and treatment update. Clin. Obstet. Gynecol. 45, 259-272.